Myasthenia gravis classification: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Rheumatology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 13:54, 29 June 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Myasthenia gravis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myasthenia gravis classification On the Web |
|
American Roentgen Ray Society Images of Myasthenia gravis classification |
|
Risk calculators and risk factors for Myasthenia gravis classification |
Overview
The most widely accepted classification of myasthenia gravis is the Myasthenia Gravis Foundation of America Clinical Classification.[1] This classification system categorizes the disease by the muscles that are predominantly effected.
Classification
- Class I: Any eye muscle weakness, possible ptosis, no other evidence of muscle weakness elsewhere
- Class II: Eye muscle weakness of any severity, mild weakness of other muscles
- Class IIa: Predominantly limb or axial muscles
- Class IIb: Predominantly bulbar and/or respiratory muscles
- Class III: Eye muscle weakness of any severity Moderate weakness of other muscles
- Class IIIa: Predominantly limb or axial muscles
- Class IIIb: Predominantly bulbar and/or respiratory muscles
- Class IV: Eye muscle weakness of any severity, severe weakness of other muscles
- Class IVa: Predominantly limb or axial muscles
- Class IVb: Predominantly bulbar and/or respiratory muscles (Can also include feeding tube without intubation)
- Class V: Intubation needed to maintain airway
References
- ↑ Jaretzki A, Barohn RJ, Ernstoff RM; et al. (2000). "Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America". Neurology. 55 (1): 16–23. PMID 10891897.